Gad Berdugo, CTV Executive-in-Residence and former Chief Business Officer of Editas, talks with CTV’s Ofra Weinberger about why he is so excited about the potential for precision medicine, gene editing, and advanced diagnostics for improving human health; about the waves of new therapeutics that may come in the years ahead for thousands of genetic diseases; and about the business model opportunities and challenges behind these new innovations.